Psyched Wellness Ltd.

Recent News

  • Psyched Wellness Receives DTC Eligibility

    Toronto, Ontario--(Newsfile Corp. - April 14, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE:5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that its common shares are now eligible for electronic clearing and settlement through the Depository Trust Company ("DTC"). DTC is a subsidiary of the Depository Trust...

    2021-04-14 11:36 AM ET
  • Psyched Wellness Initiates Study on AME-1 Extract for Gut Health

    Toronto, Ontario--(Newsfile Corp. - March 30, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the company has signed an additional agreement with its CRO partner, KGK Science to further study the anti-inflammatory nature of AME-1. KGK Science specializes in nutraceutical product testing and development and is leading the pre-clinical trials for Psyched. This...

    2021-03-30 7:00 AM ET
  • Psyched Wellness Submits a Provisional Patent Application For AME-1

    Toronto, Ontario--(Newsfile Corp. - March 17, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the company has submitted a provisional patent application with the United States Patent and Trademark office, to cover the Company's unique extraction processes for its proprietary Amanita muscaria extract AME-1.The application was submitted on March 12, 2021 as App....

    2021-03-17 4:00 AM ET
  • Psyched Wellness Announces Changes to the Board of Directors

    Toronto, Ontario--(Newsfile Corp. - March 15, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that Janeen Stodulski has been appointed as a director of the Corporation. Psyched also announced that Chris Hazelton...

    2021-03-15 5:04 PM ET
  • Psyched Wellness Provides Update on Pre-Clinical Trial of Its Muscimol Extract AME-1

    Toronto, Ontario--(Newsfile Corp. - March 2, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the company has received the results from its Maximum Tolerated Dosage (MTD) study conducted by KGK Science, a licensed CRO in Canada. "I am pleased to share the positive results from the individual studies that our CRO is conducting...

    2021-03-02 4:00 AM ET
  • Psyched Wellness Closes $6,603,000 Bought Deal Private Placement

    Toronto, Ontario--(Newsfile Corp. - February 17, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company"), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that further to its press releases dated January 21, 2021 and January 22, 2021, it has closed the bought deal private placement for total gross proceeds of $6,603,000 (the "Offering"). In connection with the Offering, the Company issued an aggregate of...

    2021-02-17 10:59 AM ET
  • Psyched Wellness Provides Update on Antioxidant and Anti-Inflammatory Study of Muscimol

    Toronto, Ontario--(Newsfile Corp. - February 4, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to share an update on the previously announced study to determine the therapeutic values of muscimol for antioxidant and anti-inflammatory purposes via a nerve derived immunity and neuroprotective modulation models.The study, led by Brian Tancowny, a scientific advisor to the company,...

    2021-02-04 4:00 AM ET
  • Psyched Wellness to Participate in Canaccord Genuity's New Paradigms and Treatment Approaches in Mental Health Conference

    Toronto, Ontario--(Newsfile Corp. - February 2, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched") a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushroom derived products, is pleased to announce its CEO and COO will be presenting at Canaccord Genuity Group Inc.'s upcoming conference; New Paradigms and Treatment Approaches in Mental Health.Psyched Wellness CEO, Jeff Stevens and COO, David Shisel will be presenting on Thursday February 4,...

    2021-02-02 1:24 PM ET